z-logo
Premium
The impact of dupilumab treatment on SARS‐CoV ‐2 T cell responses in atopic dermatitis patients
Author(s) -
Ungar Benjamin,
Hartzell Susan,
LozanoOjalvo Daniel,
Ghalili Sabrina,
Bose Swaroop,
Golant Alexandra K.,
Tan Kathryn,
Estrada Yeriel D.,
Singer Giselle K.,
Pavel Ana B.,
Cravedi Paolo,
GuttmanYassky Emma
Publication year - 2023
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.15540
Subject(s) - dupilumab , atopic dermatitis , immunology , medicine , vaccination , immune system , antibody , monoclonal antibody , eczema area and severity index

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom